Literature DB >> 24338204

Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator.

Fanny Boudghène-Stambouli1, Stéphane Boulé, Céline Goéminne, Edward Botcherby, Christelle Marquié, Claude Kouakam, Laurence Guédon-Moreau, Guillaume Schurtz, Pascal de Groote, Nicolas Lamblin, Marie Fertin, Emmanuel Robin, François Brigadeau, Didier Klug, Dominique Lacroix, Jonathan Meurice, Ludivine Wissocque, André Vincentelli, Salem Kacet.   

Abstract

PURPOSE: This study aims to study the clinical implications of the concomitant use of a left ventricular assist device (LVAD) and an implantable cardioverter-defibrillator (ICD).
METHODS: In this retrospective study, all patients who underwent LVAD (Heart Mate II) implantation with concomitant ICD therapy at our institution between June 2007 and August 2012 were included. We sought to investigate (1) the electromagnetic interference between LVAD and ICD telemetry, (2) the effect of LVAD implantation on right ventricular (RV) lead parameters and (3) the ventricular tachyarrhythmias (VAs) that occur post-LVAD implantation.
RESULTS: Of the 23 patients (53 ± 9 years, 73 % male, LVEF 19 ± 9 %) included, ICD telemetry was lost in four patients post-LVAD implantation (Saint-Jude-Medical Atlas V-193, V-240, V-243, and Sorin CRT-8750), prompting either use of a metal shield (n = 1), a change in position of the programmer head (n = 1) or ICD replacement (n = 2). LVAD implantation was associated with a decrease in both RV signal amplitude (p = 0.04) and RV impedance (p < 0.01), and a trend towards an increased RV pacing threshold (p = 0.08), without affecting clinical outcome. Eleven patients (47.8 %) experienced VAs after LVAD implantation, which on the whole were well tolerated. Their occurrence was strongly linked to a history of VAs before device implantation (p < 0.01).
CONCLUSIONS: Electromagnetic interference between LVADs and ICD telemetry may necessitate ICD replacement. LVAD placement is associated with significant changes in RV lead parameters that have minimal clinical significance. VAs occur in approximately half of LVAD patients seen and their occurrence is strongly related to a history of VAs prior to LVAD implantation.

Entities:  

Mesh:

Year:  2013        PMID: 24338204     DOI: 10.1007/s10840-013-9854-y

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  26 in total

1.  Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients.

Authors:  Marwan M Refaat; Toshikazu Tanaka; Robert L Kormos; Dennis McNamara; Jeffrey Teuteberg; Steve Winowich; Barry London; Marc A Simon
Journal:  J Card Fail       Date:  2011-12-22       Impact factor: 5.712

2.  Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads.

Authors:  Amrut V Ambardekar; Christopher M Lowery; Larry A Allen; Anne P Cannon; Joseph C Cleveland; Joann Lindenfeld; Andreas Brieke; William H Sauer
Journal:  J Card Fail       Date:  2010-01-08       Impact factor: 5.712

3.  Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator.

Authors:  Daniel J Cantillon; Khaldoun G Tarakji; Dharam J Kumbhani; Nicholas G Smedira; Randall C Starling; Bruce L Wilkoff
Journal:  Heart Rhythm       Date:  2010-01-04       Impact factor: 6.343

4.  Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator.

Authors:  Jennifer Cowger Matthews; Daphne Betley; Fred Morady; Frank Pelosi
Journal:  J Cardiovasc Electrophysiol       Date:  2007-03-31

5.  Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients.

Authors:  Andrew Brenyo; Mohan Rao; Sushma Koneru; William Hallinan; Samit Shah; H T Massey; Leway Chen; Bronislava Polonsky; Scott McNitt; David T Huang; Ilan Goldenberg; Mehmet Aktas
Journal:  J Cardiovasc Electrophysiol       Date:  2011-11-14

6.  Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; Karen L Ulisney; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2010-01       Impact factor: 10.247

7.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

8.  Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.

Authors:  David Foo; Bruce D Walker; Dennis L Kuchar; Charles W Thorburn; Andre Tay; Christopher S Hayward; Peter Macdonald; Anne Keogh; Eugene Kotlyar; Philip Spratt; Paul Jansz
Journal:  Pacing Clin Electrophysiol       Date:  2009-07       Impact factor: 1.976

9.  Implantable defibrillator with left ventricular assist device compatibility.

Authors:  Hanno Oswald; Gunnar Klein; Martin Strüber; Ajmal Gardiwal
Journal:  Interact Cardiovasc Thorac Surg       Date:  2009-02-17

10.  Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.

Authors:  Michael Kühne; Michaela Sakumura; Stephen Scott Reich; Jean-Francois Sarrazin; Darryl Wells; Nagib Chalfoun; Thomas Crawford; Warangkna Boonyapisit; Laura Horwood; Aman Chugh; Eric Good; Krit Jongnarangsin; Frank Bogun; Hakan Oral; Fred Morady; Francis Pagani; Frank Pelosi
Journal:  Am J Cardiol       Date:  2009-12-22       Impact factor: 2.778

View more
  5 in total

Review 1.  Electromagnetic interference between implantable cardiac devices and continuous-flow left ventricular assist devices: a review.

Authors:  Jonathan S Gordon; Elizabeth J Maynes; Thomas J O'Malley; Behzad B Pavri; Vakhtang Tchantchaleishvili
Journal:  J Interv Card Electrophysiol       Date:  2021-01-12       Impact factor: 1.900

2.  No Electromagnetic Interference Occurred in a Patient with a HeartMate II Left Ventricular Assist System and a Subcutaneous Implantable Cardioverter-Defibrillator.

Authors:  Ajay Sundara Raman; Farshad Raissi Shabari; Biswajit Kar; Pranav Loyalka; Ramesh Hariharan
Journal:  Tex Heart Inst J       Date:  2016-04-01

Review 3.  Implantable Cardioverter-defibrillator Therapy in the Patient with a Left Ventricular Assist Device: Still a Black Box.

Authors:  Travis Richardson; Christopher R Ellis
Journal:  J Innov Card Rhythm Manag       Date:  2017-12-15

4.  2019 EACTS Expert Consensus on long-term mechanical circulatory support.

Authors:  Evgenij V Potapov; Christiaan Antonides; Maria G Crespo-Leiro; Alain Combes; Gloria Färber; Margaret M Hannan; Marian Kukucka; Nicolaas de Jonge; Antonio Loforte; Lars H Lund; Paul Mohacsi; Michiel Morshuis; Ivan Netuka; Mustafa Özbaran; Federico Pappalardo; Anna Mara Scandroglio; Martin Schweiger; Steven Tsui; Daniel Zimpfer; Finn Gustafsson
Journal:  Eur J Cardiothorac Surg       Date:  2019-08-01       Impact factor: 4.191

5.  A Review of New-Onset Ventricular Arrhythmia after Left Ventricular Assist Device Implantation.

Authors:  Jianwei Shi; Xinyi Yu; Zhigang Liu
Journal:  Cardiology       Date:  2022-04-28       Impact factor: 2.342

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.